Skip to main content
Premium Trial:

Request an Annual Quote

Shanghai Genomics and Centocor Pen Drug-Discovery Alliance

NEW YORK (GenomeWeb News) – Shanghai Genomics and Centocor will research inflammatory signaling pathways, GNI said today.
The drug-discovery collaboration, which will initially be for one and a half years, will explore receptor protein interactions and intracellular signaling cascades.
Financial details were not disclosed.